fda stopping semaglutide ends shortage, closing the door on compounded Wegovy, Ozempic FDA Declares Shortage of Novo

Follow your surgical team instructions exactly

Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference

Those risk factors include a personal or family history of medullary thyroid cancer and a diagnosis of multiple endocrine neoplasia syndrome type 2 (MEN2)

In male fetuses, it can interfere with the development of external genitalia by blocking the same androgen receptors it blocks in your skin and follicles